ArticleMolecular immunology2007

A polymorphism in the type one complement receptor (CR1) involves an additional cysteine within the C3b/C4b binding domain that inhibits ligand binding.

Daniel J Birmingham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.